Melanotan II 10mg Peptide | Third-Party Tested | RemedyX Labs
Order Melanotan II 10mg research peptide online from RemedyX Labs. Verified batch COAs confirm purity and identity. Secure checkout, competitive pricing, and fast shipping.
Melanotan II is a synthetic melanocortin receptor agonist, active at MC1R and MC4R, studied in controlled laboratory models of pigmentation biology and melanocortin receptor signaling. Every batch is independently tested by a third-party laboratory to confirm identity and purity, with batch-specific Certificates of Analysis (COA) available for full transparency. For laboratory research use only. Not for human or animal use. Not intended for diagnostic, therapeutic, clinical, or commercial use.
- Price: 39.00 USD
- In stock
- Purity: 99%+
- CAS Number: 121062-08-6
- Molecular Formula: C50H69N15O9
- Molecular Weight: 1024.2
- Specification: 10mg/vial
- Contents: Lyophilized Powder
- Appearance: White to Off-White
- Intended Use: Research Only
- SKU: RXL-SKU-0021
Cited Research
Evaluation of Melanotan-II, a Superpotent Cyclic Melanotropic Peptide
This study provides an initial scientific evaluation of the potency and properties of the cyclic melanotropic peptide, Melanotan II.
PubMed
The Melanocortin Agonist, Melanotan II, Enhances Proceptive Sexual Behaviors
Researchers investigated the role of the melanocortin agonist Melanotan II in modulating proceptive sexual behaviors.
PubMed
Melanotan II injection resulting in systemic toxicity and rhabdomyolysis
This report documents a case of systemic toxicity and rhabdomyolysis observed following the administration of Melanotan II.
PubMed, 2012
Melanoma associated with the use of melanotan-II
The study investigates a potential association between the use of Melanotan II and the development of melanoma.
PubMed, 2014
Inhibitory Effect of the Melanocortin Receptor Agonist Melanotan-II (MTII) on Feeding Depends on Dietary Fat Content and not Obesity in Rats on Free-Choice Diets
Researchers analyzed whether the inhibitory effect of Melanotan II on feeding in rats is influenced by dietary fat content rather than obesity.
PubMed, 2015
Melanocortinergic activation by melanotan II inhibits feeding and increases uncoupling protein 1 messenger ribonucleic acid in the developing rat
This study explored how melanocortinergic activation by Melanotan II affects feeding behavior and uncoupling protein 1 expression in developing rats.
PubMed, 2007
Unabated anorexic and enhanced thermogenic responses to melanotan II in diet-induced obese rats despite reduced melanocortin 3 and 4 receptor expression
The investigators examined anorexic and thermogenic responses to Melanotan II in obese rats despite altered melanocortin receptor expression.
PubMed, 2004
Determination of melanotan-II in rat plasma by liquid chromatography/tandem mass spectrometry: determination of pharmacokinetic parameters in rat following intravenous administration
Researchers developed a liquid chromatography-mass spectrometry method to determine the pharmacokinetic parameters of Melanotan II following intravenous administration in rats.
PubMed, 2002
Melanotan II User Experience: A Qualitative Study of Online Discussion Forums
This qualitative study analyzed user experiences regarding Melanotan II through data collected from online discussion forums.
PubMed, 2021
Changes of melanocytic lesions induced by Melanotan injections and sun bed use in a teenage patient with FAMMM syndrome
This case study monitored changes in melanocytic lesions in a teenager with FAMMM syndrome following Melanotan II use and tanning bed exposure.
PMC, 2013
Changes in Oral Mucosa Associated with Melanotan II Injections
Describes oral-mucosal changes associated with reported injections.
PMC, 2026
An overview of benefits and risks of chronic melanocortin-1 receptor agonist use
Discusses melanocortin agonists including Melanotan II and their benefit-risk uncertainties.
PMC, 2024